NuvOx Pharma Receives Phase I STTR Grant from NINDS for Preclinical Studies in Stroke
NuvOx Pharma, a Tucson based biotechnology company, has received a $478,000 NIH Phase I Small Business Technology Transfer (STTR) grant from the National...
Source: pr.com